Mycoril (Clotrimazole)

Clotrimazole, the active ingredient in Mycoril, is an imidazole antifungal presented as a topical formulation for skin use. It treats superficial fungal infections such as ringworm, athlete's foot and cutaneous candidiasis in adults and children when applied to the affected area. GNH USA supplies Mycoril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clotrimazole is used to treat fungal skin infections by targeting the dermatophyte and yeast organisms that cause them. - Dermatophytosis (ringworm): eliminates the fungal infection of skin, hair and nails. - Tinea corporis: clears body ringworm lesions and relieves associated itching. - Tinea pedis: resolves athlete's foot symptoms and eradicates the causative fungus. - Cutaneous candidiasis: treats yeast infections of the skin, reducing redness and discomfort.

Topical clotrimazole may cause local skin reactions, most of which are mild and transient.

Common Side Effects: - Burning sensation at the application site - Itching or mild irritation - Redness of the skin - Dryness or peeling - Mild rash or erythema - Stinging feeling

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Contact dermatitis with swelling - Blistering or severe skin irritation - Extensive rash covering large areas - Systemic absorption leading to liver enzyme changes (rare) - Persistent ulceration or necrosis of skin.

When using Mycoril, follow these safety measures to minimize risks. - Avoid application on broken or inflamed skin: limit use to intact epidermis. - Do not apply near eyes, mouth or mucous membranes: risk of irritation. - Use only external application: not for internal or systemic use. - Keep out of reach of children: prevent accidental ingestion. - Discontinue use and seek medical advice if severe irritation occurs. - Store at room temperature: keep in the original container, protect from moisture and light.

Clotrimazole may interact with other topical agents or systemic antifungals.

Major Interactions (Avoid): - Concurrent use with other topical antifungal creams containing azoles: may increase local irritation. - Simultaneous systemic azole therapy (e.g., fluconazole): can raise systemic clotrimazole levels, increasing risk of adverse effects.

Moderate Interactions (Monitor Closely): - Co‑application with topical corticosteroids: may reduce antifungal efficacy. - Use under occlusive dressings: enhances absorption, monitor for skin reactions. - Combination with other skin irritants (e.g., harsh soaps): may exacerbate local irritation.